Surface (S)-layer proteins are model systems for studying protein glycosylation in bacteria and simultaneously hold promises for the design of novel, glyco-functionalized modules for nanobiotechnology due to their 2D self-assembly capability. Understanding the mechanism governing S-layer glycan biosynthesis in the Gram-positive bacterium Paenibacillus alvei CCM 2051
Introduction
Bacterial oligosaccharyl:protein transferases (OTases) play a key role in the biosynthesis of glycoproteins, which, in turn, are frequent mediators of interactions between bacterial cells and their environments. A wellknown example is the highly reduced ability of Campylobacter jejuni to colonize mouse intestines when it is deficient in its general protein N-glycosylation system by mutation of either the N-OTase PglB or the prominent glycosylation target PglE [1] . In recent years, interest in biotechnological applications of bacterial protein glycosylation systems has been arising with the aim of efficiently producing recombinant bio-active glycoconjugates for vaccination or drug targeting purposes [2, 3] .
Bacterial OTases have been characterized in several Gram-negative organisms [4] . PglB has been identified as the N-OTase of Campylobacter jejuni, glycosylating more than 50 proteins at the Asp/Glu-X-Asn-X-Ser/Thr consensus site [5] . PilO and PglL have been found to be the O-OTases responsible for pilin glycosylation in Pseudomonas aeruginosa and Neisseria meningitidis, respectively [6, 7] . Recently, homologues of PglL in Vibrio cholerae and Burkholderia thailandensis have been shown to be O-OTases [8] . In all of these cases, glycosylation is a membrane-associated process, with the involvement of a lipid-linked oligosaccharide substrate anchored to the cytoplasmic membrane and an OTase as an integral membrane protein. In most bacteria, similar to eukarya, it appears that O-glycosylation sites are not defined by any primary sequence. However, recent data support the presence of a consensus sequence for Oglycosylation in Bacteriodetes species [9, 10] .
In Gram-positives, the best studied protein glycosylation systems are those responsible for the O-glycosylation of S-layer proteins in Firmicutes. These organisms are completely covered by a monolayer of self-assembled S-layer glycoproteins, providing a selection advantage to the bacterium in its natural habitat.
The most detailed data on S-layer protein glycosylation is available for Geobacillus stearothermophilus NRS 2004/3a and Paenibacillus alvei CCM 2051
T [11] [12] [13] . In both organisms, a single S-layer protein species is multiply decorated with a distinct type of polysaccharide, which consists of an adaptor saccharide and an elongated glycan chain composed of a distinct number of repeating units. The repeating structure of the P. alvei CCM 2051
(1-to specific tyrosine residues of the S-layer protein SpaA. The glycan from G. stearothermophilus is less complex being a poly-L-rhamnan which is linked to Thr 590, Thr 620 and Ser 794 of the S-layer protein SgsE via an adaptor resembling that of P. alvei without the branching part [14, 15] . The required enzymatic machinery is encoded in a single S-layer glycosylation (slg) gene cluster [16] . In G. stearothermophilus NRS 2004/3a, each step of the S-layer glycan assembly line could be attributed to a distinct enzyme from its slg gene cluster using in vitro experiments [12] . Finally, an OTase is required for the transfer of the complete glycan chain onto the protein. In the case of P. alvei CCM 2051 T , the corresponding enzyme is assumed to be the predicted membrane protein WsfB, the only protein from the slg gene locus, to which (in addition to WsaA, which is encoded in a very short upstream coding sequence) no distinct function could be attributed in the glycan biosynthesis so far. The architecture of the slg gene locus of P. alvei is similar to that of G. stearothermophilus, even though it is not a polycistronic cluster as is the case for G. stearothermophilus [17] . Sequence based annotation of the slg gene locus-enzymes identified WsfB as the putative O-OTase in this organism. Both, WsfB and the G. stearothermophilus ortholog WsaB, contain a Wzy_C domain, which is characteristic of O-OTases as well as O-antigen ligases and polymerases. However, only the former function is required for S-layer protein glycosylation in these organisms.
WsfB function is of special interest, because the glycosylation sites in the P. alvei S-layer protein SpaA are exclusively tyrosine residues, while the vast majority of O-glycosylation in prokarya and eukarya is targeted to serine and threonine residues. Tyrosine glycosylation is only prominent in glycogen, where glycogenin catalyses the transfer of glucose from UDP-glucose to its own Tyr 194 residue [18] , and in the insect humoral factor D-glucosyl-L-tyrosine [19] . The O-glycosylation system of P. alvei might, thus, serve as a tool-box for uncommon glycoengineering, complementing the huge potential of known Ser/Thr O-glycosylation systems.
In this work, the possibility to genetically manipulate P. alvei CCM 2051
T is exploited to introduce mutations in the Wzy_C domain of WsfB and to study the functional outcome. Further, a transmembrane topology model of WsfB is built on the activity measurements of translationally fused alkaline phosphatase A (PhoA) and green fluorescence protein (GFP), which have complementary activity in the cytoplasm and periplasm, respectively. Following up reports on relaxed substrate specificity of the O-OTases PilO and PglL, transfer of heterologous glycans onto SpaA using WsfB was attempted in distinct Escherichia coli and Salmonella enterica strains that would provide defined lipid-linked sugar substrates for the WsfB enzyme.
Materials and Methods

Genetic Constructs
Point mutations and deletions were introduced into WsfB by overlap extension PCR using genomic DNA of P. alvei CCM 2051 T (Czech Collection of Microorganisms, CCM). Two parts of the WsfB sequence were amplified separately, one comprising the part upstream of the site to mutate, the other being the respective downstream part. The reverse primer of the upstream part and the forward primer of the downstream part were overlapping and included the mutation or deletion that was consequently introduced in both stretches. In a second round of PCR, these two amplicons were mixed with overall forward and reverse primers and a product was obtained that contained the desired mutation or deletion. All mutated WsfB sequences were cloned into the Bacillus/E. coli shuttle and expression vector pEXALV [13] via SphI/ KpnI. The primer pair WsfB_SphI_for/WsfB_KpnI_rev was used as outermost primers and the inner primers are named according to the introduced mutation or deletion. The point mutations introduced were R353A, D359A, H395A, Q400A, and E404A. The deletions were WsfB-Δ353-362 and WsfBΔ383-405. A truncated form WsfB1-714 was obtained by using the respective reverse primer WsfB_K714_KpnI_rev.
WsfB was translationally fused to PhoA at residues E147, S184, R224, F257, E292, T342, K362, E385, L402, T431, F461, S489, E610, G679, and the native C-termiCopyright © 2012 SciRes. AiM
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539 nal E781. WsfB-PhoA fusions were cloned by inserting WsfB amplified with the primer pair WsfB_XhoI_for/ WsfB_KpnI_rev upstream of PhoA into the expression vector pHA1-PhoA via XhoI/KpnI. WsfB was translationally fused to GFP at residues E147, S184, R224, F257, E292, T342, E385, L402, T431, F461, S489, E711, and E781. For GFP fusions, WsfB amplified using the primer pair WsfB_NcoI_for/WsfB_KpnI_rev and was inserted into the fusion insertion vector pET28-GFP [20] upstream of GFP via NcoI/KpnI. SpaA including its native signal peptide was cloned into the expression vector pMLBAD using the primer pair spaA_KpnI_for/spaA_PstI_rev and the restriction sites KpnI/PstI. WsfB was cloned into the expression vector pEXT20 using the primer pair WsfB_BamHI_for/ WsfB_HindIII_rev and the restriction sites BamHI/HindIII.
Cloning was performed according to standard procedures using E. coli DH5α. Restriction enzymes, T4 DNA ligase and DNA preparation kits were purchased from Fermentas and used according to the manufacturer's instructions.
The primers used in this study are listed in Table 1 .
Mutational Analysis
The constructs containing mutated WsfB variants in pEXALV were transformed into P. alvei CCM 2051 T WsfB:L1.LtrB cells (henceforth abbreviated ΔWsfB) by electroporation [13] . The transformed bacteria were cultivated in LB medium containing 10 µg/mL chloramphenicol at 37˚C and 200 rpm to an OD 600 1. Cells were harvested at 14,000 × g for 1 min and the pellet was resuspended in 20 µL of Laemmli buffer per OD unit and incubated for 5 min at 95˚C. Samples were analyzed by SDS-PAGE (10% gel) using Coomassie Brilliant Blue G250 and periodic acid Schiff (PAS) staining [21] for proteins and glycoproteins, respectively. Protein bands corresponding to non-glycosylated and glycosylated SpaA appear at 109 kDa and 155 kDa/240 kDa, respectively [17] .
PhoA Activity Assay
PhoA and GFP activity assays were performed as described previously [22] ; (D. Daley, personal communication). Cells of the PhoA deficient strain E. coli CC118 were transformed with the WsfB-PhoA fusion constructs. Transformed cells and untransformed control cells were cultivated in LB medium at 37˚C overnight, diluted 1:100 in fresh medium, and grown for 2.5 h under the same conditions. Ampicillin was added at a concentration of 100 µg/mL, when appropriate. Expression of WsfB-PhoA fusion proteins was induced with L-arabinose at a final concentration of 0.16% and cells were incubated for additional 1.5 h. Iodoacetamide was added to a final concentration of 0.8 mM from a 200 mM iodoacetamide stock solution in 10 mM Tris-HCl, pH 8.0 (buffer A). Cells were incubated for 5 min followed by harvesting from a 1-mL culture by centrifugation at 5000 × g (4˚C, 15 min). Pellets were washed with buffer A, containing 10 mM MgSO 4 and 1 mM iodoacetamide. Pellets were resuspended in 800 µL of the same buffer without MgSO 4 . OD 600 of the resuspension was recorded. 100 µL of this suspension were added to 900 µL of 1 M Tris-HCl, pH 8.0, containing 0.1 mM ZnCl 2 and 1 mM iodoacetamide. 4 µL of a 0.1% SDS solution and 4 µL of chloroform were added, samples were mixed thoroughly and incubated at 37˚C for 5 min with shaking. Samples were subsequently cooled on ice for 5 min, followed by addition of 100 µL of 0. 
with 0.1 being the dilution factor when transferring the cell suspension to the activity buffer.
GFP Activity Assay
E. coli BL21 cells were transformed with the WsfB-GFP fusion constructs. Transformed cells were grown to OD 600 0.4 at 37˚C in LB medium. Expression was induced with IPTG at a final concentration of 0.4 mM and incubation was continued for 2 h. Cells were harvested by centrifugation at 5000 × g (4˚C, 15 min). Cell pellets from 1-mL culture aliquots were resuspended in 200 µL of 0.2 M Tris-HCl, pH 8.0, containing 15 mM NaCl and 50 mM EDTA, and incubated in the dark at 25˚C for 2 h. Fluorescence was measured at 512 nm from excitiation at 485 nm in a TECAN Infinite F200 plate reader. Obtained values were normalized by sample OD 600 to account for variations in cell density. 
Western Blotting
Expression of plasmid encoded proteins (WsfB, SpaA, WsfB-GFP and WsfB-PhoA fusion proteins) was confirmed by Western-blotting as described previously [24] , using rabbit antibodies against WsfB and SpaA, and mouse anti-GFP antibody (Roche) as well as mouse antiPhoA antibody (Invitrogen). The secondary antibodies were IRDye 680LT goat anti-rabbit or IRDye 800CW goat anti-mouse (LI-COR), respectively, and detection was performed accordingly at 700 nm or 800 nm using the Odyssey imaging system (LI-COR).
Heterologous Co-Expression of WsfB and SpaA
Cells of E. coli CWG702 and S. enterica SL3749 were transformed with both pMLBAD-SpaA and pEXT20-WsfB simultaneously. Cells were grown in LB-medium, containing 50 µg/mL trimethoprim and 100 µg/mL ampicillin, at 37˚C and shaking at 200 rpm. At an OD 600 0.6 expression was induced by the addition of L-arabinose to a final amount of 0.02% and IPTG to a final concentration of 1 mM. Cells were harvested after 4 h of expression.
Results
Conserved Domains and Functional Association
WsfB is a 781-amino acids protein (calculated molecular mass, 87.5 kDa) containing a conserved Wzy_C domain (pfam 04932) between the amino acid residues 351 and 414. This domain is typically found in a class of sugar transferring enzymes including O-antigen polymerases, O-antigen ligases and OTases. To our current understanding, the S-layer glycosylation pathway of P. alvei requires only the latter. When comparing PAS-stained SDS gels of whole cell extracts of wild-type P. alvei CCM 2051 T and WsfB cells, numerous glycoprotein bands are visible. The distinct S-layer glycoprotein bands appearing at 155 kDa and 240 kDa [17] are the only glyco-stained bands missing in the knock-out strain (Figure 1) . Therefore, the function of WsfB is confined to the S-layer protein glycosylation pathway, as was expected from its coding sequence being located within the slg gene locus. Together, the unique function within P. alvei and the presence of the conserved Wzy_C motif are clear indications of the suggested O-OTase function of WsfB. 
Transmembrane Topology
A transmembrane topology model of WsfB was developed based on the translational fusion of PhoA and GFP [22] , respectively, to defined C-terminal truncations of WsfB. The fusion constructs with PhoA were expressed in the PhoA-deficient strain E. coli CC118. The activity of PhoA, being only functional when located in the periplasm of the host cells, was assessed photometrically using p-nitrophenyl phosphate as a substrate. Fusions to GFP were expressed in E. coli BL21 cells. The activity of GFP, which is restricted to the cytoplasm, was measured by fluorometry. Using both, PhoA and GFP signals, from twelve fusion sites, a rough pattern of cytoplasmically and extra-cytopasmically located regions of WsfB was obtained. The experimentally determined locations were used as a set of restrictions in the transmembrane topology prediction program HMMTOP [25] . The resulting topology model for WsfB is shown in Figure 2 .
The model shows a clear orientation of WsfB towards the extra-cytoplasmic space. Four loops of considerable size are found at the outer side of the membrane, while the cytoplasmic loops are not larger than 22 amino acid residues and probably serve only a structural purpose.
The model contains a 79-residue cytoplasmic tail, which might be of functional importance. The conserved Wzy_C region is found to encompass the majority of the central extra-cytoplasmic loop. The location of this domain at the exterior is consistent with finding of the glycosylation reaction to occur outside the cytoplasm (B. Janesch, unpublished data). A large loop is present at the very C-terminus of WsfB from amino acid 515 to 734. Within this loop, a tetratricopeptide repeat (TPR) motif, which is a mediator of protein-protein interaction [26] , is found between residues 519 and 625. The topology model contains 13 membrane spanning helices, which is a reasonably high number related to both, the size of the protein and to similar models of other Wzy_C-like enzymes [27, 28] .
Activity measurements from one additional fusion site (E711), for which only a WsfB-GFP fusion construct was obtained and three additional sites with only a WsfBPhoA fusion (K362, E610, G679) were not included for calculating the model. However, the absolute values of these signals were amongst the highest of their respective kind and, thus, confirmed the locations of these sites in the model.
Mutational Analysis
To identify amino acids within the Wzy_C region directly involved in the function of WsfB, point mutations to alanine were introduced between residues 353 and 404. The mutation sites were selected based on their conser-vation between the Wzy_C domains of WsfB, PilO, PglL and the Wzy_C HMM consensus sequence, excluding Pro and Gly residues (Figure 3) . Mutated residues are also indicated in Figure 2 .
None of the mutated WsfB sequences was able to reconstitute WsfB function upon homologous expression in P. alvei CCM 2051 T ΔWsfB cells (Figure 4) . Also deletions of residues R353-K362 and K383-T405 within the Wzy_C region rendered WsfB non-functional. This confirms the Wzy_C domain as a critical region for WsfB function, however, this does not allow for the conclusion of either of the selected residues being of particular importance.
It has to be noted that the truncation of the C-terminal tail of WsfB at K715 also resulted in loss of function. A WsfB variant containing a spontaneous mutation of Glu 516 to His, which is located at the start of the large fourth extra-cytoplasmic loop in the topology model, was able to fully reconstitute the wild-type glycosylation phenoltype in ΔWsfB cells. As a control, non-mutated native WsfB is shown to be able to fully reconstitute the glycosylation when expressed in the knock out strain (Figure  4) .
Substrate Specificity of WsfB
Assuming that WsfB would have a relaxed substrate specificity in heterologous hosts comparable to what has been reported to other OTases from Gram-negative bacteria [8, 29, 30] , WsfB and its native target protein SpaA were co-expressed in E. coli CWG702 and S. enterica SL3749, intending to directly confirm its catalytic function. The native S-layer signal peptide has been shown previously to allow for export of an S-layer protein to the periplasm of E. coli cells [31] and it was employed here to direct SpaA to the periplasm of the Gram-negative host cells, where protein glycosylation is known to occur. Both host strains are deficient in their O-antigen ligase and, thus, accumulate lipid-linked oligosaccharides in the cytoplasm, which makes them suitable to check for utilization of these sugar substrates to be transferred by WsfB. The S. enterica SL3749 O-glycan has the reducing end structure L-Rha-β1,3-D-Gal, which besides the anomeric configuration of the Gal residue matches the reducing end of the P. alvei CCM 2051 T S-layer glycan adaptor saccharide L-Rha-1,3-D-Gal. The repeating unit structure of the E. coli CWG702 O-glycan is (D-Man) n -1,3-D-GlcNAc, thus providing a rather non-natural substrate for WsfB to be recognized. To analyse for the transfer of these glycans onto SpaA by rWsfB, Western blots of whole cell extracts of the respective expression cultures with anti-SpaA antibody were performed and the glycosylation status of SpaA was checked by PAS staining after separation by SDS-PAGE. However, neither approach for assaying WsfB enzyme activity was successful (data not shown), pointing to more specific requirements of the WsfB/SpaA glycosyla- tion system than those reported for the Gram-negative OTase systems studied so far.
Discussion
The utilization of bacterial protein glycosylation systems is aimed at the production of tailor-made glycoproteins in bacterial cell factories [32, 33] . The capability of such production systems requires the detailed understanding of the involved carbohydrate-active enzymes, with OTases being key modules. Here we focused on the predicted O-OTase WsfB from the P. alvei S-layer glycosylation system that allows for the formation of a rare tyrosine O-glycosidic linkage. Our results strongly suggest that WsfB indeed transfers the elongated S-layer glycan onto the tyrosine glycosylation sites.
The O-OTase-characteristic Wzy_C motif of WsfB shares a range of conserved amino acids with PilO and PglL (Figure 3) . Mutations of the conserved residues as well as the truncation of the C-terminal tail resulted in inactivation of WsfB. Similarly, in PilO the mutation of conserved R281 to alanine, matching R353A in WsfB, was reported to disable this enzyme [27] . Also, a C-terminal truncation led to inactivation of PilO; however the PilO "tail" is located in the periplasm in contrast to the cytoplasmic orientation in the WsfB model. A transmembrane topology model for WsfB was derived from measuring the activity of PhoA and GFP fused to several sites in WsfB. The model shows the Wzy_C region being located outside the cytoplasm, which matches the current model of S-layer glycosylation taking place in the extra-cytoplasmic space. The location of the Wzy_C region within WsfB just C-terminal of the protein sequence centre is comparable to the location in PilO and PglL, respectively. Also, the number of 13 transmembrane helices predicted for WsfB is consistent with 12 and 13 helices in the models for PilO and PglL [28] , respectively. An additional large extra-cytoplasmic loop is found at the very C-terminus of WsfB, which, like the extra-cytoplasmic tail of PglL, contains a tetratricopeptide repeat (TPR) region [26] . This region probably mediates protein-protein interaction to other enzymes of the S-layer glycosylation pathway. Potential interaction partners would have to be located on the external face of the membrane, which precludes them to the ABC-transporter and the enzymes WsfD and WsfH, which are proposed to be involved in the formation and addition of a branching glucose residue on the S-layer glycan [17] .
One remarkable feature of other OTases is their relaxed specificity towards the glycan substrate. It was therefore a worthwhile approach to use readily available though not entirely matching substrates to assess WsfB function in heterologous hosts. However, neither the O-antigen structure from E. coli CWG702 nor the glycan from S. enterica SL3749 where transferred to SpaA by recombinantly expressed WsfB. While this is not yet a proof of a restriction of WsfB function to S-layer glycan transfer in heterologous host, this observation is in line with the confinement of WsfB to the S-layer glycosylation system (Figure 1) , which contrasts the diverse native functionalities of other OTases, such as PglB.
Bacterial OTases that have been identified and characterised originate from Gram-negative organisms. The presence of similar enzymes in Gram-positives has not been shown so far [34] . WsfB has all features of a bacterial O-OTase, making it the most probable candidate for the O-OTase of P. alvei CCM 2051 T , and a promising candidate for the first O-OTase reported in Gram-positives.
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